Tilak Mendis

A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease

Mark Stacy, Dee E. Silver, Tilak Mendis et al. · Neurology · 2008 · 181 citations

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

Neurodegenerative Diseases, Medicine, Psychotropic Medication +6

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

Erich Mohr, Tilak Mendis, Kathleen Hildebrand et al. · Movement Disorders · 2000 · 87 citations · Full text

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial

Samuel Frank, Claudia Testa, David Stamler et al. · Publisher · 2016 · 44 citations

Neurodegenerative Diseases, Pharmacology, Degenerative Disease +2

Late cognitive changes in Parkinson's disease with an emphasis on dementia.

Erich Mohr, Tilak Mendis, Grimes Jd · PubMed · 1995 · 36 citations

Neurodegenerative Diseases, Cognitive Changes, Parkinson Disease +8